Ignite Creation Date:
2025-12-26 @ 10:56 AM
Ignite Modification Date:
2026-02-23 @ 11:34 AM
Study NCT ID:
NCT04177108
Status:
COMPLETED
Last Update Posted:
2024-03-27
First Post:
2019-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Triple-Negative Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Breast Neoplasms | View |
| None | Triple Negative Breast Neoplasms | View |
| None | Neoplasms by Site | View |
| None | Neoplasms | View |
| None | Breast Diseases | View |
| None | Skin Diseases | View |
| None | Paclitaxel | View |
| None | Atezolizumab | View |
| None | Ipatasertib | View |
| None | Antibodies, Monoclonal | View |
| None | Antineoplastic Agents, Phytogenic | View |
| None | Antineoplastic Agents | View |
| None | Tubulin Modulators | View |
| None | Antimitotic Agents | View |
| None | Mitosis Modulators | View |